IUHSA
ANIK icon

Itau Unibanco Holding S.A.’s Anika Therapeutics ANIK Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,200
Closed -$166K – 462
2019
Q4 		$166K Buy
+3,200
New +$186K 0.01% 318
2018
Q4 		– Sell
-2,761
Closed -$116K – 596
2018
Q3 		$116K Buy
+2,761
New +$109K 0.01% 444

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Itau Unibanco Holding S.A.'s ANIK Position: Q1 2020 in Review

Itau Unibanco Holding S.A. sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 3,200 shares — an estimated $166K sold.

Itau Unibanco Holding S.A. first reported a position in ANIK in Q3 2018 and held it in 2 quarters. The position peaked at $166K in Q4 2019. 164 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • Itau Unibanco Holding S.A. reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 3,200 Anika Therapeutics shares in Q1 2020, an estimated $166K.
  • Itau Unibanco Holding S.A. first reported a position in Anika Therapeutics in Q3 2018 and held it in 2 quarters.
  • Itau Unibanco Holding S.A.'s Anika Therapeutics position peaked at $166K in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2020, filed 15 May 2020.